EKSO.NASDAQEkso Bionics Holdings, INC

Form 4: EKSO CFO Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report

📋All filings for Ekso Bionics Holdings, INC
🔒Login to Follow

EKSO Bionics CFO Jerome Wong sold 1,238 shares of common stock to cover tax withholding obligations related to vested restricted stock awards.

Summary

  • Jerome Wong, Chief Financial Officer of EKSO BIONICS HOLDINGS, INC. (EKSO), reported a transaction on December 9, 2025.
  • The transaction involved the sale of 1,238 shares of common stock.
  • The shares were sold at a price of $4.7048 per share.
  • The purpose of the sale was to cover tax withholding obligations incurred upon the vesting and settlement of restricted stock awards.
  • These restricted stock awards were originally reported in a Form 4 filed on June 15, 2023.
  • Following the transaction, Jerome Wong directly beneficially owns 24,771 shares of common stock.
  • Additionally, Jerome Wong indirectly beneficially owns 2,876 shares through a 401(k) plan.
  • All reported amounts of securities have been adjusted to reflect a 1-for-15 reverse stock split effected by the Issuer on June 2, 2025.

Sentiment

Score: 5

Explanation: The transaction is a routine sale by an insider to cover tax obligations upon vesting of restricted stock awards, which is a common practice and does not inherently signal positive or negative company performance.

Future Outlook

NA

Industry Context

This filing is a routine insider transaction report and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

  • Shareholders: The sale is a routine tax-related transaction by an insider and is unlikely to have a significant direct impact on the company's operational performance or long-term value. It represents a minor reduction in insider ownership.

Key Dates

DateDescription
06/15/2023Original filing date for restricted stock awards that vested and led to the current tax withholding obligations.
06/02/2025Effective date of the 1-for-15 reverse stock split of EKSO Bionics common stock.
12/09/2025Date of the reported transaction where shares were sold.
12/10/2025Date the Form 4 was signed and filed.

Recommendation

hold

The sale of shares by the CFO was explicitly stated to cover tax withholding obligations from vested restricted stock awards. This is a common and often pre-planned event for executives and does not typically indicate a change in the company's fundamental prospects or the insider's long-term view. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

EKSO Bionics, Jerome Wong, CFO, Form 4, Insider Transaction, Stock Sale, Restricted Stock Awards, Tax Withholding, Reverse Stock Split

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.